Peru has new laws for using medical hashish, following the issuance of Supreme Decree (Decreto Supremo) No. 004-2023-SA on February 28 of this 12 months. The decree approves the Regulation that Regulates the Medicinal and Therapeutic Use of Hashish and Its Derivatives (Reglamento que regula el uso medicinal y terapéutico del hashish y sus derivados). The Regulation implements the provisions of Legislation No. 30681 and Legislation No. 31312.
The Regulation particulars the necessities to acquire the various kinds of hashish licenses obtainable. Licenses to import hashish and/or market hashish derivatives could also be granted to pharmaceutical laboratories and droguerías, duly licensed to function by the Peruvian authorities. Whereas in some Spanish-speaking nations the time period droguería might imply a drugstore, in Peru it’s legally outlined as a “pharmaceutical institution, which is devoted to the import, export, advertising, high quality management, storage and/or distribution of pharmaceutical merchandise, medical gadgets and medical gadgets.”
As a part of the applying course of, candidates should certify that they are going to solely promote hashish or its derivates to different licensed entities, akin to pharmacies and comparable companies, once more duly licensed to function by the Peruvian authorities. These companies aren’t in a position to legally import hashish into Peruvian companies, however they could apply for a license to market hashish derivatives.
According to the framework in another Latin American nations, akin to Colombia and Ecuador, hashish is classed as “psychoactive” (Hashish psicoactivo) or “non-psychoactive” (Hashish no psicoactivo), relying on the THC content material. Psychoactive hashish is that whose THC content material is the same as or exceeds 1%. The Regulation contemplates using each psychoactive and non-psychoactive hashish for medical and therapeutic functions. As such, each varieties of hashish could also be imported into Peru underneath the Regulation. Importers of psychoactive hashish, nevertheless, should get hold of an import certificates from the Basic Directorate of Medicine, Provides and Medicine (DIGEMID).
The Regulation additionally offers for different varieties of licenses that, whereas maybe of restricted curiosity to overseas hashish companies, are vital to stakeholders in Peru. These embody licenses for the manufacturing of hashish derivatives, which can embody authorization to develop hashish. As well as, licenses can be found for accredited affected person associations. The Regulation additionally establishes necessities for hashish prescriptions for sufferers.
Contemplating the fraught political setting in Peru, that there was bandwidth within the Palacio de Gobierno to are likely to the Regulation is by itself exceptional. Is embattled President Dina Boluarte in search of to shore up help for her authorities, by interesting to medical hashish sufferers? We see no indication of such a ploy, which is simply as nicely, since a minimum of some sufferers are unhappy with the brand new guidelines. Maybe, although, the companies set to benefit from the alternatives offered by the medical hashish market will likely be extra happy.